In Depth 16 Oct 2024
JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer?
Janus Kinase (JAK) inhibitors, a type of kinase inhibitor, are a popular class of drugs in the biopharma industry. Several have been approved to treat inflammatory diseases and cancer, and…